Rosewell Pharmaceuticals Private Limited
About Rosewell Pharmaceuticals Private Limited
Data last updated:
Rosewell Pharmaceuticals Private Limited is a private limited company based in Mumbi, Maharashtra, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 16 December 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1987PTC045603.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Mukesh Kumar and Umesh Sharma.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 230 Adhyaru Industrial Estatesunmill Compound Lower Parel Bombay – 13., Mumbi, Maharashtra, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.66 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹74,660 (net margin 45%) and EBITDA of ₹1.13 Lakh (EBITDA margin 68.2%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rosewell Pharmaceuticals Private Limited's registered office is in Mumbi, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address230 Adhyaru Industrial Estatesunmill Compound Lower Parel Bombay – 13., Mumbi, Maharashtra, India
- IndustryFinancial Services, Diversified Financial Services
To see the full contact details of Rosewell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rosewell Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rosewell Pharmaceuticals Private Limited, buy the company report.
Financials of Rosewell Pharmaceuticals Private Limited
FY 2024 filings availableRosewell Pharmaceuticals Private Limited reported revenue of ₹1.66 Lakh (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 17% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74,660 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 68.2% | ||||
| Net Profit Margin | 45% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rosewell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rosewell Pharmaceuticals Private Limited
Rosewell Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar | Director | 20 Aug 2018 | 8 Years 2 Months | Current |
| Umesh Sharma | Director | 16 Dec 1987 | 38 Years 10 Months | Current |
Auditor
Rosewell Pharmaceuticals Private Limited is audited by R S Prabhu & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S Prabhu & Associates | FY 2023 | 127010W |
Shareholding
The shareholding of Rosewell Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rosewell Pharmaceuticals Private Limited, buy the company report.
Legal cases
Rosewell Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by Procter and Gamble Hygiene and Health Care Ltd. and Ors. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Proctor and Gamble Hygiene and Health Care Ltd and Ors | Disposed |
To see the full case history of Rosewell Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rosewell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rosewell Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rosewell Pharmaceuticals Private Limited has 3 board changes on record since 1987: 2 appointments and 1 cessation. The latest: Pankaj Sharma ceased to be Director on 17 Jul 2019.
Frequently asked questions
Rosewell Pharmaceuticals is an active private limited company based in Mumbi, Maharashtra, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 16 December 1987 (39+ years old) and is registered under CIN U24200MH1987PTC045603.
Rosewell Pharmaceuticals has 2 current directors:
- Mukesh Kumar - Director
- Umesh Sharma - Director
The latest financial statements of Rosewell Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rosewell Pharmaceuticals is U24200MH1987PTC045603. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rosewell Pharmaceuticals has 2 court cases on record: 2 filed against it.
Rosewell Pharmaceuticals was incorporated on 16 December 1987, making it 39+ years old. It is registered with the Registrar of Companies, Mumbai.
Pankaj Sharma ceased to be Director on 17 Jul 2019. Mukesh Kumar was appointed as Director on 20 Aug 2018. Umesh Sharma was appointed as Director on 16 Dec 1987.
The registered office of Rosewell Pharmaceuticals is at 230 Adhyaru Industrial Estatesunmill Compound Lower Parel Bombay – 13., Mumbi, Maharashtra, India.
Rosewell Pharmaceuticals operates in the financial services industry, in the diversified financial services segment.
The compliance status of Rosewell Pharmaceuticals is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.